Table 2. Features of hepatocellular carcinoma.

	n (%)	2002–2006	2007–2011	p
a-fetoprotein	1489 (72.8)			0.492
≤ 20	374 (25.1)	119 (26.2)	255 (24.7)
20–200	261 (17.5)	72 (15.8)	189 (18.3)
>200	854 (57.4)	264 (58.0)	590 (57.1)
BCLC stage	1773 (86.7)			0.316
Very early	32 (1.8)	6 (1.3)	26 (2.0)
Early	303 (17.1)	69 (14.6)	234 (18.0)
Intermediate	1128 (63.6)	308 (65.1)	820 (63.1)
Advanced	197 (11.1)	59 (12.5)	138 (10.6)
Terminal	113 (6.4)	31 (6.6)	82 (6.3)
Metastasis	2045 (100)			0.147
Intrahepatic	118 (5.8)	23 (4,1)	95 (6.4)
Extrahepatic	216 (10.6)	60 (10.8)	156 (10.5)
No	1711 (83.7)	475 (85.1)	1236 (83.1)